Severe Alpha-2 Agonist Withdrawal Syndrome in Diabetes Mellitus

Internal Medicine - Japan
doi 10.2169/internalmedicine.35.345
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Internal Medicine

Related search

Tumor Necrosis Factor Alpha in Peripheral Neuropathy in Type 2 Diabetes Mellitus

Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Mental HealthPsychiatric Mental HealthNeurologyPsychiatryNeuroscienceSurgery
2019English

Emphysematous Cystitis With Severe Hemorrhagic Anemia Resulting From Diabetes Mellitus Type 2

Internal Medicine
Internal MedicineMedicine
2004English

Risk of Type 2 Diabetes Mellitus Following Gestational Diabetes Pregnancy in Women With Polycystic Ovary Syndrome

Journal of Diabetes Research
EndocrinologyMetabolismDiabetes
2017English

Metabolic Syndrome; Agreement Between Metabolic Syndrome Diagnostic Criteria Among Type 2 Diabetes Mellitus Patients

THE PROFESSIONAL MEDICAL JOURNAL
2017English

Antioxidants (Alpha-Tocoferol Acetate) in Therapy of Diabetes Mellitus

Problemy Endokrinologii
EndocrinologyMetabolismDiabetes
1993English

Canagliflozin Improves Risk Factors of Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus and Metabolic Syndrome

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2017English

Epidemiological Evidence of Type 2 Diabetes Mellitus, Metabolic Syndrome, and Cardiovascular Disease in Japan

Circulation Journal
MedicineCardiovascular MedicineCardiology
2012English

Lunch Energy Density and the Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus

British Journal of Nutrition
MedicineNutritionDietetics
2013English

Musculoskeletal Disorders in Type 2 Diabetes Mellitus

Sohag Medical Journal
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy